Lidocaine Buffered with J-Tip 0.25 mL, 1 mL syringe, 10:1, For Intradermal Use Only, Made by: Ent...
FDA Drug Recall #D-1221-2019 — Class II — April 12, 2019
Recall Summary
| Recall Number | D-1221-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 12, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | CMC Enterprise Pharmacy |
| Location | Charlotte, NC |
| Product Type | Drugs |
| Quantity | 705 syringes |
Product Description
Lidocaine Buffered with J-Tip 0.25 mL, 1 mL syringe, 10:1, For Intradermal Use Only, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.
Reason for Recall
Lack of sterility assurance.
Distribution Pattern
NC
Lot / Code Information
Lots: ED041901 Exp. 4/13/2019; ED051901 Exp. 4/14/2019; ED081901 Exp. 4/17/2019; ED01901 Exp. 4/18/2019; ED101901 Exp. 4/19/2019; ED111901 Exp. 4/20/2019
Other Recalls from CMC Enterprise Pharmacy
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1228-2019 | Class II | Chlorothiazide 100 mg, 3.57 mL syringe, Made by... | Apr 12, 2019 |
| D-1225-2019 | Class II | CeFAZolin 2 GM a) in NS 100 mL bag; b) 100 mg/m... | Apr 12, 2019 |
| D-1209-2019 | Class II | Dexmedetomidine 400 mcg in NS 100 mL bag, Made ... | Apr 12, 2019 |
| D-1214-2019 | Class II | Magnesium Sulfate 2 GM in NS 50 mL bag, Made by... | Apr 12, 2019 |
| D-1226-2019 | Class II | CeFAZolin 3 gm 100 mg/mL, 30 mL syringe, Made b... | Apr 12, 2019 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.